$9.390
-0.177 (-1.88%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PHAT por análisis de gráficos similares
Alphio's PHAT stock price prediction model matches the current Phathom Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.39 (-0.04%). The 1-week path is $9.24 (-1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Phathom Pharmaceuticals Inc?
Phathom Pharmaceuticals is a good buy right now due to its recent strong revenue growth, reporting $74.3 million in Q2 2026, an 88% year-over-year increase, and achieving its first operating profit of $1.6 million excluding stock-based compensation. However, the company has lowered its 2026 revenue guidance to $310-325 million, which is a significant risk. The current price of $9.18 is well below analyst targets, suggesting potential upside.
PHAT cerró en $9.39 el Tuesday, tras bajar -1.88%
Phathom Pharmaceuticals Inc (PHAT) last closed at $9.39, losing -1.88%. These facts feed the 1-day and 1-week PHAT price prediction above.
Factores de la previsión
Los factores de la previsión de Phathom Pharmaceuticals Inc (PHAT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PHAT, ordenadas por similitud.
Análisis de estacionalidad de PHAT
Historically the probability of a positive September return for PHAT is 95.35%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PHAT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $6.28 | $10.15 | $14.02 | +8.05% |
| Oct 2026 | $9.29 | $11.46 | $11.86 | +22.05% |
| Nov 2026 | $6.46 | $8.88 | $10.54 | -5.47% |
| Dec 2026 | $8.43 | $9.73 | $11.97 | +3.59% |
En 2026, se proyecta que Phathom Pharmaceuticals Inc (PHAT) oscile entre $6.28 y $14.02.
Previsión mensual de Phathom Pharmaceuticals Inc para 2026
En Sep de 2026, se proyecta que Phathom Pharmaceuticals Inc promedie $10.15, con un mínimo de $6.28 y un máximo de $14.02.
En Oct de 2026, se proyecta que Phathom Pharmaceuticals Inc promedie $11.46, con un mínimo de $9.29 y un máximo de $11.86.
En Nov de 2026, se proyecta que Phathom Pharmaceuticals Inc promedie $8.88, con un mínimo de $6.46 y un máximo de $10.54.
En Dec de 2026, se proyecta que Phathom Pharmaceuticals Inc promedie $9.73, con un mínimo de $8.43 y un máximo de $11.97.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.